|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2011-6-9
|
|
pubmed:abstractText |
The purpose of this study was to assess the efficacy and safety of 5-fluorouracil (5FU) and gemcitabine administered concurrently with radiation in patients with locally advanced, nonmetastatic pancreatic cancer.
|
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/CA03927,
http://linkedlifedata.com/resource/pubmed/grant/CA04326,
http://linkedlifedata.com/resource/pubmed/grant/CA07968,
http://linkedlifedata.com/resource/pubmed/grant/CA11789,
http://linkedlifedata.com/resource/pubmed/grant/CA12046,
http://linkedlifedata.com/resource/pubmed/grant/CA16450,
http://linkedlifedata.com/resource/pubmed/grant/CA32291,
http://linkedlifedata.com/resource/pubmed/grant/CA35279,
http://linkedlifedata.com/resource/pubmed/grant/CA45389,
http://linkedlifedata.com/resource/pubmed/grant/CA45418,
http://linkedlifedata.com/resource/pubmed/grant/CA45564,
http://linkedlifedata.com/resource/pubmed/grant/CA45808,
http://linkedlifedata.com/resource/pubmed/grant/CA47559,
http://linkedlifedata.com/resource/pubmed/grant/CA47642,
http://linkedlifedata.com/resource/pubmed/grant/CA59518,
http://linkedlifedata.com/resource/pubmed/grant/CA77406,
http://linkedlifedata.com/resource/pubmed/grant/CA77440,
http://linkedlifedata.com/resource/pubmed/grant/CA77597,
http://linkedlifedata.com/resource/pubmed/grant/CA77658
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1097-0142
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2010 American Cancer Society.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
117
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2620-8
|
|
pubmed:meshHeading |
pubmed-meshheading:21656739-Adenocarcinoma,
pubmed-meshheading:21656739-Aged,
pubmed-meshheading:21656739-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21656739-CA-19-9 Antigen,
pubmed-meshheading:21656739-Combined Modality Therapy,
pubmed-meshheading:21656739-Deoxycytidine,
pubmed-meshheading:21656739-Female,
pubmed-meshheading:21656739-Fluorouracil,
pubmed-meshheading:21656739-Humans,
pubmed-meshheading:21656739-Male,
pubmed-meshheading:21656739-Middle Aged,
pubmed-meshheading:21656739-Pancreatic Neoplasms
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma : cancer and Leukemia Group B (CALGB) 80003.
|
|
pubmed:affiliation |
Dana Farber Cancer Institute, Boston, Massachusetts; Brigham and Women's Hospital, Boston, MA 02115, USA. hmamon@lroc.harvard.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II,
Research Support, N.I.H., Extramural
|
